Decision Making and Results of Coronary Artery Bypass Grafting for Patients with Poor Left Ventricular Function

Uyar, Ihsan Sami; Şahin, Veysel; Akpınar, Mehmet Beşir; Abacilar, Feyzi; Yurtman, Volkan; Okur, Faik Fevzi; Ateş, Mehmet; Tavlı, Talat

doi:10.1532/hsf98.20121124

Cited by 5 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies have shown that CABG confers a survival benefit over medical therapy in multiple subsets of patients, including those with left main CAD (Figure 6), 9-12 triple-vessel CAD, 13 and ischemic cardiomyopathy. 1,3-7,31-33 Many of these studies were conducted before the widespread use of antiplatelet and statin therapies and before the broad recognition of benefit from beta-blockers and ACE inhibitors/ARBs. There are no RCTs that have demonstrated a survival advantage of PCI over medical therapy in patients with SIHD.…”

Section: Revascularization In Sihdmentioning

confidence: 99%

See 1 more Smart Citation

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

Aim: The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered. Structure: Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients’ interests.

show abstract

Section: Revascularization In Sihdmentioning

confidence: 99%

“…Several registry studies have supported these findings. 4-7,31-33 The use of PCI in this patient population requires more study.…”

Section: Revascularization In Sihdmentioning

confidence: 99%

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

show abstract

“…36 Studies have shown that CABG confers a survival benefit over medical therapy in multiple subsets of patients, including left main CAD (Figure 3), [36][37][38][39] triple vessel CAD, 40 and ischemic cardiomyopathy. [41][42][43][44][45][46][47][48][49]…”

Section: B-rmentioning

confidence: 99%

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

Aim: The executive summary of the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions coronary artery revascularization guideline provides the top 10 items readers should know about the guideline. In the full guideline, the recommendations replace the 2011 coronary artery bypass graft surgery guideline and the 2011 and 2015 percutaneous coronary intervention guidelines. This summary offers a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization, as well as the supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered. Structure: Recommendations from the earlier percutaneous coronary intervention and coronary artery bypass graft surgery guidelines have been updated with new evidence to guide clinicians in caring for patients undergoing coronary revascularization. This summary includes recommendations, tables, and figures from the full guideline that relate to the top 10 take-home messages. The reader is referred to the full guideline for graphical flow charts, supportive text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in the development of this guideline.

show abstract

“…1,2 Studies have demonstrated that revascularisation in the form of coronary artery bypass graft (CABG) confers survival benefit over medical treatment in patients with left main disease, triple-vessel disease (TVD) and ischaemic cardiomyopathy. [3][4][5][6][7][8][9][10][11][12][13] However, for patients with prohibitive operative risk or those with a personal preference…”

mentioning

confidence: 99%

Use of Mechanical Circulatory Support in Complex High-risk Percutaneous Coronary Intervention: A Review of Current Evidence

Sung,

Lam,

Chui

et al. 2023

J Asian Pac Soc Cardiol

View full text Add to dashboard Cite

With advances in devices and techniques of percutaneous coronary intervention (PCI), interventional cardiologists are managing patients with coronary artery disease of increasing complexity. For patients with prohibitive operative risk or who refuse bypass surgery, PCI may provide a reasonable alternative. Procedural haemodynamic stress often poses a significant challenge and is poorly tolerated in patients with reduced myocardial reserve, such as those with advanced heart failure or extreme frailty. The emergence of new mechanical circulatory support (MCS) devices has made PCI a more viable option for these high-risk patients. In this article, the authors review the existing evidence on the use of MCS in non-emergency complex and high-risk PCI, the optimal timing of initiating MCS and barriers to MCS use.

show abstract

Decision Making and Results of Coronary Artery Bypass Grafting for Patients with Poor Left Ventricular Function

Cited by 5 publications

References 22 publications

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Use of Mechanical Circulatory Support in Complex High-risk Percutaneous Coronary Intervention: A Review of Current Evidence

Contact Info

Product

Resources

About